or
forgot password

Identification of Key Blood Molecular Markers for Immunotherapy


N/A
18 Years
N/A
Not Enrolling
Both
Squamous Cell Carcinoma, Adenocarcinoma, Neoplasms

Thank you

Trial Information

Identification of Key Blood Molecular Markers for Immunotherapy


Inclusion Criteria:



1. Patients diagnosed with cancerous tumors based on biopsy or other clinical
observations.

2. Patients diagnosed with non-cancerous tumors based on biopsy or other clinical
observations.

3. Normal volunteers who do not have cancer or other medical conditions that may affect
survival.

Exclusion Criteria:

1. Patients will be excluded if, upon clinical observation, they are under a severe
septic or inflammatory condition. In these conditions, human body immune response
against sepsis or inflammation should be the predominant response, and may shield or
block the immune response against tumors.

2. Patients will be excluded if, upon clinical observation, they are under extremely
illness situation like myocardial infarction. In such a case, the immune findings may
be altered.

3. Patients will be excluded if, upon looking through their medical records, significant
information required for data analysis is missing. This is because that patients'
medical records will help us connect our research findings with their clinical
observations, and further provide guidelines for subsequent treatment options.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To identify and evaluate the presence of pre-existing immunity related markers in peripheral human blood, to identify patients who may respond to IL-12 immunotherapy

Outcome Time Frame:

3 years

Safety Issue:

No

Principal Investigator

Jeffrey A. Norton

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

VAR0017

NCT ID:

NCT00507702

Start Date:

July 2006

Completion Date:

July 2012

Related Keywords:

  • Squamous Cell Carcinoma
  • Adenocarcinoma
  • Neoplasms
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous
  • Neoplasms
  • Carcinoma
  • Carcinoma, Squamous Cell

Name

Location

Stanford University School of Medicine Stanford, California  94305-5317